Opdivo (nivolumab)

pCPA File Number: 20933

Negotiation Status:

Concluded with an LOI

Indication(s):

Head and Neck Squamous Cell Carcinoma (HNSCC)

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

PC0095-000

pCPA Engagement Letter Issued:

2017-09-29

Negotiation Process Concluded:

2017-11-20